Sophie is a dynamic, versatile, and accomplished negotiator, recognized for her leadership and problem-solving skills. She holds advanced studies in health economics, which she has combined with extensive experience in market access strategies, pricing, negotiation, stakeholder management, and health policy.
Currently, she serves as the Vice-President of Market Access and Public Affairs at Otsuka Canada Pharmaceutical. Her career began at AETMIS (now INESSS) as a health economist. She has since held several key positions in the pharmaceutical industry, including roles at Pfizer Canada, Janssen, Novartis Canada in oncology, and Idorsia. Until June of this year, she was the Vice-President of the Canadian Association for Healthcare Reimbursement.
Day 1 Oct 28, 2025
11:50 am
Panel
The Canadian market access landscape is rapidly evolving due to shifting government policies, payer dynamics, and the complexity of biopharmaceutical innovation. This session will explore key trends, including pricing and policy changes, data-driven decision-making, new funding models, equity in access and digital health solutions, while highlighting opportunities for industry stakeholder collaboration to enhance patient access.
- Impact of Pricing and Policy Changes within Canada/US, Globally,
- Navigating evidence demands for high-cost therapies and rare disease treatments, leveraging real-world evidence,
- health outcomes data, and patient-reported outcomes to meet payer evidence demands.
- Data-Driven Decision Making and the growing importance of economic modeling and burden-of-illness studies ,
- Equity of access and digital health solutions and value-based reimbursement models exploring opportunities for collaboration between industry stakeholders to improve patient access
Day 2 Oct 29, 2025
